Ipamorelin listings by strength and brand
Ipamorelin Overview
The category includes a combination listing, Ultima-IPA+CJC 5mg+5mg Ultima Pharma USA, alongside single compound Ipamorelin products. That distinction sets the range apart and gives you an important first check when comparing the available listings.
Ipamorelin appears under the broader Peptides category in several naming formats. The catalogue includes branded entries from Beligas Pharma, Deus Medical, Driada Medical EU, Sixpex USA, Ultima Pharma and XT Labs USA. It also includes Ipamorelin products marked as No Label. The available titles show 2 mg, 5 mg and 20 mg references, plus a 10 reference in the Ipamorelin 10 XT Labs USA listing.
How the Ipamorelin range is organised
Some listings name the compound directly, such as Ipamorelin 20 mg or Ipamorelin 5 Sixpex USA. Others use a brand-led format, including IPAMORELIN Deus Medical and ULTIMA-IPAMORELIN 5 MG Ultima Pharma USA. The wording matters because it identifies the presentation shown on the product page.
The range also separates regional references in some titles. Beligas Pharma appears with both USA and INT listings, while Ultima Pharma has USA and INT versions of its 5 MG product. These titles should be compared as separate catalogue entries unless the product page confirms that their details match.
Reading strength, brand and format differences
Start with the full title rather than the compound name alone. A listing marked 2 Mg should not be treated as equivalent to one marked 5 MG or 20 mg. The category also includes Ipamorelin 2 Driada Medical EU, Ipamorelin 2 No Label and Ipamorelin 2 Mg Beligas Pharma USA, which share a stated amount but differ in their naming and brand references.
- Single compound listing
- A title that identifies Ipamorelin without naming another compound.
- Combination listing
- Ultima-IPA+CJC 5mg+5mg identifies Ipamorelin and CJC in the same product title.
- Branded listing
- A product title that includes a manufacturer or brand reference such as Deus Medical, Beligas Pharma or Ultima Pharma.
- No-label listing
- An entry titled No Label, without a brand name in the recorded product title.
Packaging should be checked against the exact listing title. Compare the compound name, stated amount, brand wording and any USA, INT or EU reference shown on the product page. Product images and printed identifiers can help you confirm that the presentation matches the catalogue entry.
Checks before choosing a listing
Decide first whether you are comparing a single Ipamorelin entry or the Ultima-IPA+CJC combination. Then check the stated strength and the full brand name. If the title contains No Label, treat it as a separate presentation rather than assuming that it matches a branded product.
This category record does not establish medical suitability, regulatory status, storage conditions or instructions for use. It is product information for comparing recorded catalogue details. This information is not medical advice. Consult an appropriately qualified healthcare professional before considering use, and check the product page for storage, use and pre-order requirements before placing an order.






























